Biocompatibility of a decellularized liver scaffold in studies in vitro

Authors

  • Mariya Yu. Yurkevich International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus https://orcid.org/0000-0002-5082-5874
  • Andrei D. Dubko International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus
  • Darya B. Nizheharodava International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus
  • Maryna V. Labai International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus
  • Marina M. Zafranskaya International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus

Keywords:

decellularization, perfusion-detergent method, liver scaffold, biocompatibility, multipotent mesenchymal stromal cells, splenocytes
Supporting Agencies
This work was supported by the Belarusian Republican Foundation for Fundamental Research (grant No. M19ARM-016 dated 02.05.2019).

Abstract

The development of multicomponent threedimensional structures based on decellularized tissue is a perspective alternative for organ transplantation in end-stage liver disease. The technology of rat liver decellularization is presented which consist in sequential perfusion of organ through the portal vein and use of 0.1 % sodium dodecyl sulfate as an active solution. The absence of the cytotoxic effect of decellularized scaffolds on allogeneic splenocytes and multipotent mesenchymal stromal cells was established. The obtained liver scaffolds are biocompatible in cells cultures and correspond criteria for cell carriers.

Author Biographies

  • Mariya Yu. Yurkevich, International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus

    PhD (biology); associate professor at the department of immunology, faculty of environmental medicine

  • Andrei D. Dubko, International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus

    junior researcher at the research sector

  • Darya B. Nizheharodava, International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus

    PhD (biology), docent; associate professor at the department of immunology, faculty of environmental medicine

  • Maryna V. Labai, International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus

    senior lecturer at the department of immunology, faculty of environmental medicine

  • Marina M. Zafranskaya, International Sakharov Environmental Institute, Belarusian State University, 23/1 Daŭhabrodskaja Street, Minsk 220070, Belarus

    doctor of science (medicine), docent; head of the department of immunology, faculty of environmental medicine

References

  1. Uhl P, Fricker G, Haberkorn U, Mier W. Current status in the therapy of liver diseases. International Journal of Molecular Sciences. 2014;15(5):7500–7512. DOI: 10.3390/ijms15057500.
  2. Akamatsu N, Sugawara Y, Kokudo N. Acute liver failure and liver transplantation. Intractable and Rare Diseases Research. 2013;2(3):77–87. DOI: 10.5582/irdr.2013.v2.3.77.
  3. Gulay YS, Krasheninnikov ME, Shagidulin MY, Onishchenko NA. Hepatic tissue engineering (modern state of this problem). Russian Journal of Transplantology and Artificial Organs. 2014;16(2):103–113. Russian. DOI: 10.15825/1995-1191-2014-2-103-113.
  4. Heydari Z, Najimi M, Mirzaei H, Shpichka A, Ruoss M, Farzaneh Z, et al. Tissue engineering in liver regenerative medicine: insights into novel translational technologies. Cells. 2020;9(2):304. DOI: 10.3390/cells9020304.
  5. Hamooda M. Hepatocyte transplantation in children with liver cell failure. Electronic Physician. 2016;8(10):3096 –3101. DOI: 10.19082/3096.
  6. Wang F, Zhou L, Ma X, Ma W, Wang C, Lu Y, et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study. Transplantation Proceedings. 2014;46(1):192–198. DOI: 10.1016/j.transproceed.2013.10.042.
  7. Shagidulin MY, Onishchenko NA, Krasheninnikov ME. Transplantation of hepatocytes as the method of treatment of liver failure: experimental and clinical experience. Russian Journal of Transplantology and Artificial Organs. 2010;12(4):53–60. Russian. DOI: 10.15825/1995-1191-2010-4-53-60.
  8. Alfaifi M, Eom YW, Newsome PN, Baik SK. Mesenchymal stromal cell therapy for liver diseases. Journal of Hepatology. 2018;68(6):1272–1285. DOI: 10.1016/j.jhep.2018.01.030.
  9. Bachmann A, Moll M, Gottwald E, Nies C, Zantl R, Wagner H, et al. 3D cultivation techniques for primary human hepatocytes. Microarrays. 2015;4(1):64–83. DOI: 10.3390/microarrays4010064.
  10. Mazza G, Al-Akkad W, Rombouts K, Pinzani M. Liver tissue engineering: from implantable tissue to whole organ engineering. Hepatology Communications. 2018;2(2):131–141. DOI: 10.1002/hep4.1136.
  11. Grant R, Hay D, Callanan A. From scaffold to structure: the synthetic production of cell derived extracellular matrix for liver tissue engineering. Biomedical Physics and Engineering Express. 2018;4(6):065015. DOI: 10.1088/2057-1976/aacbe1.
  12. Coronado RE, Somaraki-Cormier M, Natesan S, Christy RJ, Ong JL, Halff GA. Decellularization and solubilization of porcine liver for use as a substrate for porcine hepatocyte culture: method optimization and comparison. Cell Transplantation. 2017;26(12):1840–1854. DOI: 10.1177/0963689717742157.
  13. Wang Y, Nicolas CT, Chen HS, Ross JJ, De Lorenzo SB, Nyberg SL. Recent advances in decellularization and recellularization for tissue-engineered liver grafts. Cells Tissues Organs. 2017;204:125–136. DOI: 10.1159/000479597.
  14. Zhou P, Lessa N, Estrada DC, Severson EB, Lingala S, Zern MA, et al. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transplantation. 2011;17(4):418–427. DOI: 10.1002/lt.22270.
  15. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011;32(12):3233–3243. DOI: 10.1016/j.biomaterials.2011.01.057.
  16. Hussein KH, Park K-M, Kang K-S, Woo H-M. Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application. Materials Science and Engineering: C. 2016;67:766–778. DOI: 10.1016/j.msec.2016.05.068.
  17. Zafranskaya MM, Lamouskaya NV, Nizheharodava DB, Yurkevich MYu, Bagatka SS, Mechkovsky SYu, et al. Morphology, growth kinetics and cell phenotype of bone marrow- and adipose tissue-derived mesenchymal stem cells. Immunopathology, allergology, infectology. 2010;4:86–93. Russian.

Downloads

Published

2021-03-12

How to Cite

Yurkevich, M. Y. ., Dubko, A. D. ., Nizheharodava, D. B. ., Labai, M. V. ., & Zafranskaya, M. M. . (2021). Biocompatibility of a decellularized liver scaffold in studies in vitro. Experimental Biology and Biotechnology, 1, 20-27. https://doi.org/10.33581/2521-1722-2021-1-20-27